Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;80(11):1461-1466.
doi: 10.1136/annrheumdis-2021-219914. Epub 2021 Jun 15.

Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies

Weng Ian Che  1 , Helga Westerlind  2 , Ingrid E Lundberg  3   4 , Karin Hellgren  2   3   4 , Ralf Kuja-Halkola  5 , Marie Holmqvist  2   3   4
Affiliations

Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies

Weng Ian Che et al. Ann Rheum Dis. 2021 Nov.

Abstract

Objectives: The magnitude of the genetic contribution to idiopathic inflammatory myopathies (IIMs) is unknown. In this project, we aimed to investigate the familial aggregation and heritability of IIM.

Methods: This is a family-based study using nationwide healthcare register data in Sweden. We matched each patient with IIM to individuals without IIM, identified their first-degree relatives and determined the IIM status among all first-degree relatives. We estimated the adjusted ORs (aORs) of familial aggregation of IIM using conditional logistic regression. In addition, we used tetrachoric correlation to estimate the heritability of IIM.

Results: We included 7615 first-degree relatives of 1620 patients with IIM diagnosed between 1997 and 2016 and 37 309 first-degree relatives of 7797 individuals without IIM. Compared with individuals without IIM, patients with IIM were more likely to have ≥1 first-degree relative affected by IIM (aOR=4.32, 95% CI 2.00 to 9.34). Furthermore, the aOR of familial aggregation of IIM in full siblings was 2.53 (95% CI 1.62 to 3.96). The heritability of IIM was 22% (95% CI 12% to 31%) among any first-degree relatives and 24% (95% CI 12% to 37%) among full siblings.

Conclusions: IIM has a familial component with a risk of aggregation among first-degree relatives and a heritability of about 20%. This information is of importance for future aetiological studies and in clinical counselling.

Keywords: dermatomyositis; epidemiology; polymyositis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: IEL has received grants from Swedish Research Council and from Region Stockholm (ALF-project), during the conduct of the study, grants and consulting fee from Bristol Myers Squibb, consulting fee from Corbus Pharmaceutical, grants from Astra Zeneca, research collaboration with aTyr Pharma, outside the submitted work.

Figures

Figure 1
Figure 1
Identification of patients with idiopathic inflammatory myopathies (IIMs) and individuals without IIM from the National Patient Register and the Total Population Register, respectively.
Figure 2
Figure 2
Point estimates with 95% CIs (grey shading) of heritability of IIM using assumed prevalence of IIM ranging from 0.004% to 0.024%, with a fixed interval of 0.0002% for (A) any first-degree relatives and (B) full siblings only. IIM, idiopathic inflammatory myopathy.
See this image and copyright information in PMC

References

    1. Aggarwal R, Oddis CV. Managing myositis: a practical guide. Springer International Publishing, 2019.
    1. Miller FW, Lamb JA, Schmidt J, et al. . Risk factors and disease mechanisms in myositis. Nat Rev Rheumatol 2018;14:255–68. 10.1038/nrrheum.2018.48 - DOI - PMC - PubMed
    1. Miller FW, Chen W, O'Hanlon TP, et al. . Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes. Genes Immun 2015;16:470–80. 10.1038/gene.2015.28 - DOI - PMC - PubMed
    1. Rothwell S, Cooper RG, Lundberg IE, et al. . Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups. Ann Rheum Dis 2016;75:1558–66. 10.1136/annrheumdis-2015-208119 - DOI - PMC - PubMed
    1. Acosta-Herrera M, Kerick M, González-Serna D, et al. . Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases. Ann Rheum Dis 2019;78:311–9. 10.1136/annrheumdis-2018-214127 - DOI - PMC - PubMed

Publication types